Efficacy and Safety of Topical Timolol for Infantile Hemangioma in the Early Proliferative Stage

This randomized clinical trial evaluates the efficacy and safety of timolol maleate solution, 0.5%, for the early treatment of infantile hemangioma in infants younger than 60 days.
Source: JAMA Dermatology - Category: Dermatology Source Type: research